4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001209191-16-110141
Options or other derivatives
- Chief Financial Officer acquired 262,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| LOAR MATTHEW M Chief Financial Officer | 2016-03-21 | Grant or award · Employee Stock Option (Right to Buy) | +262,500 | 262,500 | D | ||
Loading xslF345X03/doc4.xml…